Page 2 of 11, showing 50 records out of 506 total, starting on record 51, ending on 100
| Year(s) |
Title |
|
2002 |
Canadian Genomics Conference – Genome Canada, “Atlas of Genomic Profiles of Steroid Action”, Montreal (May 2002) |
|
2002 |
First World Congress on Hormonal and Genetic Basis of Sexual Differentiation Disorders, Phoenix (May 2002) |
|
2002 |
10th World Congress of Gynecological Endocrinology, Plenary Lecturer, “SERMs and their Multiple Actions in Support of Women’s Health”, Wroclaw, Poland (September 2002) |
|
2002 |
Consensus Conference, Dall’Ipertrofia Prostatica Benigna al Cancro Localizzato della Prostata, “Hormonal Therapy in Localised Prostate Cancer”, Rome (October 2002) |
|
2002 |
11th International Congress on Hormonal Steroids & Hormones and Cancer, “DHEA and Bone”, Fukuoka, Japan (October 2002) |
|
2001 |
U.S. Endocrine Society Meeting (2001): Current Developments in Menopaue Management, “Intracrinology (Locally-Produced Androgens and Estrogens) in Menopause ”, Denver (June 2001) |
|
2001 |
VII International Congress of Andrology, Plenary Debate on « Screening of Prostate Cancer », Montreal (June 2001) |
|
2001 |
Reasons for Hope 2001 - Canadian Breast Cancer Research Initiative, Plenary session on “New Developments in Breast Cancer Research”, “Les modulateurs sélectifs des récepteurs des estrogènes et la sant |
|
2001 |
6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “A Strong Candidate Prostate Cancer Predisposition Gene at Chromosome 17p”, Geneva (February 2001) |
|
2001 |
6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “Key Role of GnRH Agonists in the First Pivotal Studies Shown to Improve Survival in Localized Prostate Cancer”, Geneva |
|
2001 |
11th International Prostate Cancer Update, “The Quebec Screening Study”, Vail (February 2001) |
|
2001 |
11th International Prostate Cancer Update, “Hormone Therapy Mardekly Decreases Deaths in Localized Disease”, Vail (February 2001) |
|
2001 |
11th International Prostate Cancer Update, “Susceptibility Genes for Prostate Cancer“, Vail (February 2001) |
|
2001 |
2001 Congress on Uro-Oncology: A Canada-Mexico Alliance, Ixtapa (January 2001) |
|
2001 |
3rd Croatian Congress on Menopause and Gynecological Endocrinology, “Role of Androgens in Women and Potential Use of DHEA as Hormonal Replacement Therapy”, Dubrovnik (August 2001) |
|
2001 |
3rd Croatian Congress on Menopause and Gynecological Endocrinology, “EM-652 (SCH-57068), an Ideal 4th-Generation SERM for Protection of Women’s Health ”, Dubrovnik (August 2001) |
|
2001 |
9th World Congress of Gynecological Endocrinology, “SERMs – From Pure Estrogen Antagonists to Complete Agonists”, Hong Kong (December 2001) |
|
2001 |
International Workshop – Androgens 2001, “Androgens and Prostate Cancer”, Montpellier (December 2001) |
|
2001 |
3rd Macedonian Symposium on Urology, “Status of Androgen Blockade in Prostate Cancer in 2001: Impact on Survival”, Thessaloniki (November 2001) |
|
2001 |
Third International FGOG Meeting, Endocrine Treatment and Prevention of Breast and Gynaecological Cancers, “The Advantageous Profile of EM-652- (SCH-57068) for Women’s Health Objectives”, Bruxelles (N |
|
2001 |
North American Menopause Society, Symposium on The Role of Androgen Therapy in Post-Menopausal Women, “Multiple Sources and Physiology of Androgens in Women”, New Orleans (October 2001) |
|
2001 |
Annual Female Sexual Function Forum – Plenary and State-of-the-Art Lecture, “Role of Steroid Hormones as they Pertain to Female Sexual Functions”, Boston (October 2001) |
|
2001 |
Annual Female Sexual Function Forum: Androgen Deficiency Syndrome in Women: Implications and Mechanisms and Treatments, “Role of Androgens and their Precursor DHEA in Women”, Boston (October 2001) |
|
2001 |
First World Congress – Update in Androgen Disorders, “Major Impact on Survival of Androgen Blockade in Localized Prostate Cancer”, Gubbio, Italy (September 2001) |
|
2000 |
19th Joint Meeting of the British Endocrine Societies and European Federation of Endocrine Societies, "17?-Hydroxysteroid Dehydrogenases : A Series of Key Highly Specific Enzymes of Sex Steroid Format |
|
2000 |
Symposium sur les estrogènes : de la recherche à la pratique médicane – cancers hormono-dépendants et ménopause, « Les antiestrogènes purs - Pure Antiestrogens », Montpellier (March 2000) |
|
2000 |
Symposium sur les estrogènes : de la recherche à la pratique médicane – cancers hormono-dépendants et ménopause, « Production intracellulaire d’estrogènes – Intracellular Production of Estrogens », Mo |
|
2000 |
Congress of Greek Urological Association, « Antiandrogen and Prostatic Cancer », Athens (January 2000) |
|
2000 |
1st International Congress on Surgery of Endocrine Glands, « Intracrinology : Basic and Clinical Aspects », Athens (January 2000) |
|
2000 |
Ninth International Congress on Anticancer Treatment, "Prostate Cancer and Combined Androgen Blockage: Towards Year 2000", Paris (February 1999) |
|
2000 |
Annual Meeting of the Canadian Society of Endocrinology and Metabolism, Androgens and Antiandrogens in Clinical Endocrinology, “Inhibitors of Androgen Formation and Action in Prostatic Diseases”, Hali |
|
2000 |
Les Estrogènes; de la recherche à la pratique médicale (cancers hormono-dépendants et ménopause). « Les antiestrogènes purs », Marseilles (March 2000) |
|
2000 |
International Symposium on Prostate Cancer, National Cancer Institute, « Prostate Cancer Screening. Pros», Genova (March 2000) |
|
2000 |
American Chemical Society Meeting, Symposium on Selective Estrogen Receptor Modulators, "EM-652 (SCH-57068): First Pure Response-Specific ER Regulator (Pure SERR) having Activities Ranging from Pure A |
|
2000 |
NIH Endocrine Rounds, Endocrinology and Hormone-Sensitive Cancers and Menopause (March 2000) |
|
2000 |
8th World Congress of Gynecological Endocrinology, « DHEA Replacement Therapy as Source of Androgens and Estrogens at Menopause » Florence (December 2000) |
|
2000 |
Aromatase 2000 and the Third Generation, “EM-652/SCH-57068: a Unique SERM having Pure Antiestrogenic Activity in the Mammary Gland and Endometrium”, Port Douglas, Australia (November 2000) |
|
2000 |
2000 Canadian Diabetes Association/Canadian Society of Endocrinology and Metabolism Annual Meeting, “Androgens and Antiandrogens in Clinical Endocrinology – Strategies to Block the Formation and Actio |
|
2000 |
3rd Teupitz Colloquium on Basic Research in Endocrine Dermatology, “Endocrine Dermatology” “Intracrinology in the Skin”, Berlin (September 2000) |
|
2000 |
Second International Symposium on Signal Transduction in Health and Disease (STADY II), GnRH Analogs in Reproduction and Cancer », « The Crucial Role of GnRH Analogues in the Prolongation of Survival |
|
2000 |
82nd Annual Meeting of the US Endocrine Society, CMES Ancillary Symposium “Beyond Receptors : The Emerging Role of Enzyme Modulators”, « The Intracrine Concept and Tissue-Specific Response », “Intracr |
|
1999 |
7th World Congress of Gynecological Endocrinology "Genomic and Non-Genomic Steroid Hormone Effects", "Potential of DHEA as Hormone Replacement Therapy at Menopause", Buenos Aires (April 1999) |
|
1999 |
7th World Congress of Gynecological Endocrinology "Endocrine Aspects Involving the Hypothalamo-Pituitary Adrenal Axis", "Intracrinology: its Role in Human Disease", Buenos Aires (April 1999) |
|
1999 |
The Royal Society of Medicine: Section of Urology and the British Prostate Group, "The Impact of Basic Science on Screening, Treatment and Quality of Life - the Quebec Screening Study ", London (April |
|
1999 |
Ninth International Congress on Anticancer Treatment, "Update on Combined Androgen Blockade", Paris (February 1999) |
|
1999 |
10th World Congress on Human Reproduction, "Potential of DHEA as Hormone Replacement Therapy", Salvador de Bahia, Brazil (May 1999) |
|
1999 |
Opening Conference, 28e Congrès de l'Association des Archivistes du Québec, "Rôle de la recherche dans la qualité des soins de santé", Québec (June 1999) |
|
1999 |
2nd International Consultation on Prostate Cancer, World Health Organization, International Union Against Cancer, "Management of Newly Diagnosed Metastatic Prostate Cancer", Paris (June 1999) |
|
1999 |
9th International World Congress on the Menopause, International Menopause Society, "Mechanisms of Sex Steroid Formation and Action", Yokohama, Japan (October 1999) |
|
1999 |
National Oncology Forum, NCI, “PSA Screening: Decrease in Mortality Rate”, Chicago (October 1999) |